These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23301711)

  • 1. Trends in the 2012 Eisai Oncology Digest: insurance and cost obstacles in cancer treatment.
    Am J Manag Care; 2012 Dec; 18(5 Spec No.):SP222-3. PubMed ID: 23301711
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer History, Health Insurance Coverage, and Cost-Related Medication Nonadherence and Medication Cost-Coping Strategies in the United States.
    Zhao J; Zheng Z; Han X; Davidoff AJ; Banegas MP; Rai A; Jemal A; Yabroff KR
    Value Health; 2019 Jul; 22(7):762-767. PubMed ID: 31277821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rewarding value creation to promote innovation in oncology: The importance of considering the global product life cycle.
    Garrison LP
    Oncologist; 2010; 15 Suppl 1():49-57. PubMed ID: 20237218
    [No Abstract]   [Full Text] [Related]  

  • 4. Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?
    Zafar SY; Peppercorn JM
    J Clin Oncol; 2017 Jul; 35(19):2113-2116. PubMed ID: 28459612
    [No Abstract]   [Full Text] [Related]  

  • 5. Tackling Cost: A Prescription for Spending Wisely.
    Tempero M
    J Natl Compr Canc Netw; 2019 Jun; 17(6):633. PubMed ID: 31200360
    [No Abstract]   [Full Text] [Related]  

  • 6. Managed care & medical oncology: the focus is on value.
    Danielson E; Demartino J; Mullen JA
    J Natl Compr Canc Netw; 2010 Sep; 8 Suppl 7():S28-37. PubMed ID: 20947721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral/infusion cancer drug parity begins to raise health plan costs.
    Carroll J
    Manag Care; 2012 Jan; 21(1):7-8. PubMed ID: 22334937
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.
    American Society of Clinical Oncology
    J Oncol Pract; 2018 Mar; 14(3):187-192. PubMed ID: 29091534
    [No Abstract]   [Full Text] [Related]  

  • 9. Can treatment costs be tamed?
    Malakoff D
    Science; 2011 Mar; 331(6024):1545-7. PubMed ID: 21436438
    [No Abstract]   [Full Text] [Related]  

  • 10. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The high cost of cancer drugs and what we can do about it.
    Siddiqui M; Rajkumar SV
    Mayo Clin Proc; 2012 Oct; 87(10):935-43. PubMed ID: 23036669
    [No Abstract]   [Full Text] [Related]  

  • 12. Ethical and value issues in insurance coverage for cancer treatment.
    Brock DW
    Oncologist; 2010; 15 Suppl 1():36-42. PubMed ID: 20237216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Top-up insurance for cancer drugs.
    Sikora K
    Br J Hosp Med (Lond); 2007 Jun; 68(6):288-9. PubMed ID: 17639822
    [No Abstract]   [Full Text] [Related]  

  • 14. Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
    Low E;
    J Clin Oncol; 2007 Jun; 25(18):2635-6; author reply 2637-8. PubMed ID: 17577049
    [No Abstract]   [Full Text] [Related]  

  • 15. Reducing the Cost of Cancer Care: When Less Is More.
    Tempero M
    J Natl Compr Canc Netw; 2017 Jul; 15(7):853. PubMed ID: 28687571
    [No Abstract]   [Full Text] [Related]  

  • 16. Charting the Course: Use of Clinical Pathways to Improve Value in Cancer Care.
    Malin JL
    J Clin Oncol; 2020 Feb; 38(4):367-371. PubMed ID: 31804871
    [No Abstract]   [Full Text] [Related]  

  • 17. Obstacles to affordable cancer treatments.
    Dusetzina SB; Muluneh B; Khan T; Richards KL; Keating NL
    N C Med J; 2014; 75(4):257-60. PubMed ID: 25046090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Individual therapeutic experiments. Ethical problems exemplified in oncology].
    Rippe KP
    Internist (Berl); 1999 Nov; 40(11):1243-6. PubMed ID: 10636722
    [No Abstract]   [Full Text] [Related]  

  • 19. In the Era of Cost-Effectiveness Analysis, Affordability Is a Limiting Factor for Patients' Access to Innovative Cancer Treatments.
    Aguiar PN; Adashek JJ; Roitberg F; Noia Barreto CM; Del Giglio A; Lopes GL
    Value Health Reg Issues; 2019 Dec; 20():47-50. PubMed ID: 30856543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost of insurance.
    Lancet Oncol; 2005 Aug; 6(8):537. PubMed ID: 16094750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.